Changing Trends in Organisms Causing Neonatal Sepsis and Their Antibiotic Sensitivity

Published On: 25 Apr, 2024 12:01 PM | Updated On: 25 Apr, 2024 2:17 PM

Changing Trends in Organisms Causing Neonatal Sepsis and Their Antibiotic Sensitivity

Neonatal sepsis remains a significant challenge for healthcare providers caring for newborns and infants. Babies are particularly vulnerable to bacterial infections, with rates ranging from 1 to 10 per 1000 live births globally.

One concerning aspect is the increasing resistance of bacteria to antibiotics; this is even more pronounced in developing countries due to the lack of regulations, easy access to antibiotics, and poor sanitation.

The types of bacteria causing neonatal sepsis are constantly changing, and the emergence of resistant strains adds complexity to the problem. 

A recent study on organisms causing neonatal sepsis found that Klebsiella pneumoniae and Escherichia coli are the most common gram-negative bacteria, while Coagulase-negative Staphylococcus and Staphylococcus aureus are prevalent among gram-positive bacteria. Fungal infections are mainly caused by Candida albicans. Alarmingly, 30% of the identified bacteria are resistant to multiple antibiotics, with a significant portion of Klebsiella bacteria possibly producing carbapenemase. Furthermore, all study infants tested positive for New Delhi metallo-β-lactamase, indicating a concerning trend. The prevalence of this enzyme in Klebsiella pneumoniae causing neonatal sepsis has increased significantly over the past three years.

Hence, it is necessary to monitor resistance patterns closely and use antibiotics judiciously. Proactive measures are required to combat the growing threat of antibiotic-resistant neonatal sepsis and protect the health of newborns worldwide.

Govindaraju G, Rajaiah B, Ramakrishnan S. et al. Changing Patterns of Organisms Causing Neonatal Sepsis and Their Antimicrobial Sensitivity Profile in a Tertiary Center - A Prospective Study. Indian J Pediatr. 2024. https://doi.org/10.1007/s12098-024-05116-y

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks